3 Medical Devices Stocks to Sell Now

by Portfolio Grader | July 30, 2012 11:07 am

The overall ratings of three Medical Devices stocks are down on Portfolio Grader[1] this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

Boston Scientific‘s (NYSE:BSX[2]) rating falls this week to an F (“strong sell”), down from last week’s D (“sell”) last week. Boston Scientific is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. BSX also rates an F in Portfolio Grader’s specific subcategory of Earnings Momentum. The stock price has dropped 6% over the past month, worse than 2% increase the S&P 500 has seen over the same period of time. To get an in-depth look at BSX, get Portfolio Grader’s complete analysis of BSX stock[3].

Meridian Bioscience (NASDAQ:VIVO[4]) is on the decline this week, earning a D (“sell”) after receiving a C (“hold”) last week. Meridian Bioscience manufactures diagnostic test kits, bulk antigens, antibodies and bioresearch reagents used by researchers and other diagnostic manufacturers. Share prices fell 14.1% over the past month. As of July 30, 14.3% of outstanding Meridian Bioscience shares were held short.

For more information, get Portfolio Grader’s complete analysis of VIVO stock[5].

The rating of Dentsply International (NASDAQ:XRAY[6]) slips from a C to a D. Dentsply International designs and manufactures a range of dental products. For a full analysis of XRAY stock, visit Portfolio Grader[7].

Louis Navellier’s proprietary Portfolio Grader[8] stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here[9].

Source URL: https://investorplace.com/2012/07/3-medical-devices-stocks-to-sell-now-bsx-vivo-xray/

---